mynth
11/2026100%Add-on / Bolt-on

Flora acquired by JBS

BRAZIL Consumer Products / Personal & Household / Hygiene & Beauty Brands EV $500M–1.5bn

Context

JBS agreed on 9 November 2026 to acquire the whole of Flora from J&F Group, its own controlling shareholder, at an enterprise value of $500M–1.5bn representing an EV/revenue multiple of 1x–3x. The equity consideration of 367 million dollars is payable entirely in JBS treasury Class A shares and depositary receipts, with the acquirer assuming Flora’s debt, a structure that leaves the net leverage ratio unchanged and preserves the group’s cash. Completion was expected during December 2026, subject to customary conditions. Flora manufactures and sells soaps, shampoos, deodorants, cosmetics and laundry and household cleaning products in Brazil, under brands including Minuano, Francis, Neutrox and OX. The company ranks among the five largest Brazilian producers of bath and laundry products, operates five manufacturing plants, seven distribution centres and a research facility, and employs more than 4,200 people. Revenue reached $450–900M, or 2.9 billion reais, over the twelve months to September 2026. The two companies share a common origin, Flora having begun as the hygiene and cleaning division of JBS before its separation in 2007, since when they have maintained a commercial relationship under which JBS supplies the beef tallow entering into soaps and cleaning products. That relationship underpins the industrial logic of the transaction, since slaughtering cattle produces hides, bones, fat and collagen alongside the meat, and the value of those by-products depends on what they can be turned into. JBS established Genu-in in 2022 to develop applications for bovine collagen and launched a skin ingredient derived from it in 2025, while operating biotechnology centres in Brazil and Spain. Owning a personal care manufacturer provides an outlet for such ingredients and a distribution network through which to sell them.

-> Deep-dive in Retail & Consumer market trends

Ent. Value

$500M–1.5bn

Equity Value

[members only]

Multiples

EV / Revenue

1x–3x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (USD)

Year
Rev
EBITDA
EBIT
2026
$450–900M
$25–50M
[members only]
2025
$450–900M
$25–50M
[members only]

Similar deals in Consumer Products

Similar deals in Consumer Products
DateAcquirerTargetCountrySector
11/2026AUTHENTIC BRANDS GROUPLEEUNITED STATESFashion & Apparel
10/2026GALDERMAZO SKIN HEALTHUNITED STATESHygiene & Beauty Brands
10/2026ANTA SPORTSPUMAGERMANYSport
09/2026INFLEXIONMANUCURISTFRANCEHygiene & Beauty Brands
09/2026BELLE BRANDSVEGAMOURUNITED STATESHygiene & Beauty Brands
09/2026WHITE SPACE GROUP WSGNASTY GALUNITED STATESFashion & Apparel
09/2026PORTOBELLO CAPITALMARTINEZ OTEROSPAINHome & DIY
09/2026CAUDALIE GROUPTALMFRANCEHygiene & Beauty Brands
09/2026PUIGISDINSPAINHygiene & Beauty Brands
09/2026EXTRAVAGANZA BEAUTYROJA LONDONUNITED KINGDOMHygiene & Beauty Brands

REFERENCES

Valuation range: EV $500M–1.5bn

Revenue range: $450–900M

EBITDA range: $25–50M

EV/Revenue range: 1x - 3x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Flora by JBS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: flora

FAQ

What transaction does this page cover?

This page covers JBS’s acquisition of 100% of Flora, a Brazilian company specialised in Personal & Household, in 2026, as an add-on transaction expanding an existing business platform.

How was the acquisition of Flora by JBS valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the $500M–1.5bn band, its EV/EBITDA multiple within the 10x - 18x range, and its EV/revenue multiple within the 1x - 3x range. Exact figures are available to members.

What were Flora’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Flora generated annual revenue estimated in the $450–900M range and EBITDA in the $25–50M bracket (FY 2026). Detailed financial figures are available to members.

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.